Finance

Lists
002566:SHE
Jilin Jian Yisheng Pharmaceutical Co Ltd
CN¥5.96
-1.49%
(-0.090) 1D
Oct 30, 3:04:03 PM GMT+8  ·   CNY
All symbols
SymbolPriceChange% Change
Generating top insights for 002566...
Open
CN¥6.03
High
CN¥6.23
Low
CN¥5.93
Mkt. cap
1.97B
Avg. vol.
5.73M
Volume
5.07M
Dividend
1.34%
Quarterly dividend
CN¥0.02
Ex-dividend date
May 29, 2026
P/E ratio
75.54
52-wk high
CN¥9.68
52-wk low
CN¥5.76
EPS
CN¥0.08
Shares outstanding
330.95M
No. of employees
2K
Open
CN¥6.03
High
CN¥6.23
Low
CN¥5.93
Mkt. cap
1.97B
Avg. vol.
5.73M
Volume
5.07M
Dividend
1.34%
Quarterly dividend
CN¥0.02
Ex-dividend date
May 29, 2026
P/E ratio
75.54
52-wk high
CN¥9.68
52-wk low
CN¥5.76
EPS
CN¥0.08
Shares outstanding
330.95M
No. of employees
2K
News stories
From web sources and news partners
About Jilin Jian Yisheng Pharmaceutical Co Ltd
CEO-
Employees1.62K
FoundedJun 11, 1997
Headquarters-
SectorPharmaceutical industry
Websiteyisheng-pharm.com
Previous reportsAll values in CNY
Loading Previous Earnings...
Revenue
Net income
All values in CNY
Dec 2025
Mar 2026
Jun 2026
Sep 2026
Revenue
163.98M
178.61M
159.87M
96.85M
Cost of goods sold
51.97M
44.72M
40.73M
33.95M
Cost of revenue
51.97M
44.72M
40.73M
33.95M
Research and development expenses
3.58M
4.54M
4.01M
4.00M
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
105.49M
115.30M
105.16M
51.79M
Operating expense
113.25M
125.70M
114.52M
42.87M
Total operating expenses
165.23M
170.42M
155.25M
76.82M
Operating income
-1.25M
8.19M
4.62M
20.03M
Other non operating income
-640.61K
-39.52K
46.60K
-12.22M
EBT including unusual items
2.24M
18.90M
13.23M
-10.88M
EBT excluding unusual items
-2.76M
8.20M
10.96M
15.17M
Income tax expense
-2.27M
2.68M
1.62M
-3.63M
Effective tax rate
-101.06%
14.18%
12.27%
33.40%
Other operating expenses
3.89M
3.88M
3.58M
-9.17M
Net income
4.87M
16.14M
10.69M
-5.59M
Net profit margin
2.97%
9.04%
6.68%
-5.77%
Earnings per share
-
-
-
-
Interest and investment income
1.83M
3.14M
9.02M
7.36M
Interest expense
-2.70M
-3.09M
-2.73M
-
Net interest expenses
-871.44K
55.92K
6.29M
7.36M
Depreciation and amortization charges
-
-
-
-
EBITDA
8.38M
17.81M
14.24M
29.66M
Gain or loss from assets sale
-400.97K
-
-
-
Upcoming events
AI content may include mistakes. Learn more
HelpSend feedbackPrivacyTermsDisclaimer
Google apps